Ionic mechanisms for prolongation of refractoriness and their proarrhythmic and antiarrhythmic correlates

American Journal of Cardiology

Volumn 78, Issue 4 A, 1996, Pages 12-16

  Roden, Dan M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; QUINIDINE; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; TERFENADINE;

ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; CHANNEL GATING; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; HEART ARRHYTHMIA; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HUMAN; PRIORITY JOURNAL; TORSADE DES POINTES;

EID: 0029822088     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00448-1     Document Type: Conference Paper

References (30)

1. Fozzard HA, Arnsdorf MF. Cardiac electrophysiology. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System: Scientific Foundations, 2nd ed, vol 1. New York: Raven Press, 1991:63-98.
2. Snyders DJ, Bennett PB, Hondeghem LM. Mechanisms of drug-channel interactions. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System: Scientific Foundations, 2nd ed, vol 2. New York: Raven Press, 1991:2165-2193.
3. Singh BN, Nademanee K. Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations. Am Heart J 1985;109:421-430.
4. The CAST Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
5. Nattel S, Pedersen DH, Zipes DP. Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog. Cardiovasc Res 1981;15:80-85.
6. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW, and the CAST Investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med 1991;324:781-788.
7. Akiyama T, Pawitan Y, Greenberg H, Kuo C-S, Reynolds-Haertle RA, and the CAST Investigators. Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. Am J Cardiol 1991;68:1551-1555.
8. Roden DM. Current status of class III antiarrhythmic therapy. Am J Cardiol 1993;72(suppl):44B-49B.
9. Lynch JJ, Coskey LA, Montgomery DG, Lucchesi BR. Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death. Am Heart J 1985;109:949-958.
10. Chi L, Mu D-X, Driscoll EM, Lucchesi BR. Antiarrhythmic and electrophysiologic actions of CK-3579 and sematilide in a conscious canine model of sudden coronary death. J Cardiovasc Pharmacol 1990;16:312-324.
11. Kou WH, Nelson SD, Lynch JJ, Montgomery DG, DiCarlo L, Lucchesi BR. Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death. J Am Coll Cardiol 1987;9:359-365.
12. Mason JW, for the Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452-458.
13. Greene HL, for the CASCADE Investigators. The CASCADE study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. Am J Cardiol 1993;72(suppl):70F-74F.
14. Roden DM, Thompson KA, Hoffman BF, Woosley RL. Clinical features and basic mechanisms of quinidine-induced arrhythmias. J Am Coll Cardiol 1986;8:73A-78A.
15. Roden DM, Hoffman BF. Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers: relationship to potassium and cycle length. Circ Res 1985;56:857-867.
16. Sicouri S, Antzelevitch C. A subpopulation of cells with unique electro-physiological properties in the deep subepicardium of the canine ventricle: the M cell. Circ Res 1991;68:1729-1741.
17. +-induced early afterdepolarizations in Purkinje fibers. J Cardiovasc Electrophysiol 1994;5:933-944.
18. Campbell RM, Woosley RL, Iansmith DHS, Roden DM. Lack of triggered automaticity despite repolarization abnormalities due to bepridil and lidoflazine. PACE 1990;13:30-36.
19. 2+ current. Circ Res 1989;64:977-990.
20. January CT, Moscucci A. Cellular mechanisms of early afterdepolarizations. (Review.) Ann NY Acad Sci 1992;644:23-32.
21. k blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium. J Cardiovasc Pharmacol 1990;16:401-410.
22. Hondeghem LM, Snyders DJ. Class III antiarrhythmic agents have a lot of potential, but a long way to go: Reduced effectiveness and dangers of reverse use dependence. Circulation 1990;81:686-690.
23. Sager PT, Uppal P, Follmer C, Antimisiaris M, Pruitt C, Singh BN. Frequency-dependent electrophysiologic effects of amiodarone in humans. Circulation 1993;88:1063-1071.
24. Snyders DJ, Knoth KM, Roberds SL, Tamkun MM. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol Pharmacol 1992;41:322-330.
25. + channel cloned from human heart. Mol Pharmacol 1993;44:1240-1245.
26. Yang T, Prakash C, Roden DM, Snyders DJ. Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomers. Br J Pharmacol 1995;115:267-274.
27. Kr) in AT-1 cells: concentration-, time-, voltage-, and use-dependent effects. Circulation 1995;91:1799-1806.
28. Balser JR, Bennett PB, Hondeghem LM, Roden DM. Suppression of time-dependent outward current in guinea pig ventricular myocytes: actions of quinidine and amiodarone. Circ Res 1991;69:519-529.
29. Roden DM. Treatment of cardiovascular disorders: arrhythmias. In: Melmon KL, Morrelli HF, Hoffman BB, Nierenberg DW, eds. Clinical Pharmacology: Basic Principles in Therapeutics. McGraw-Hill, 1992:151-185.
30. Roden DM. Early afterdepolarizations and torsades de pointes: implications for the control of cardiac arrhythmias by prolonging repolarization. Eur Heart J 1993;14H:56-61.